Arvee Laboratories (India)- HY1-FY21 PAT dips at Rs. 71.31 lacs against Rs.1.26 crore in HY1-FY20
Arvee Laboratories (India)– HY1-FY21 revenue at Rs.18.68 crore against Rs. 26.98 crore in HY1-FY20
Company : Arvee Laboratories (India) Limited
Arvee Laboratories (India) declared its standalone financial results for the HY1 ended 30th September, 2020 marking a fall in post-tax gains against the net profit in a year ago period.
Following are the standalone financials at Arvee Laboratories (India) in HY1-FY20-21:- PAT shrinks at Rs. 71.31 lacs compared to net profit of Rs. 1.26 crore in the corresponding period last year. - Standalone Earnings per share for the current half year stands at Rs.1.29 as against EPS of Rs.2.30 in previous year same period. - Revenue stood at Rs.18.68 crore against Rs26.98 crore in a year ago period.
By the end of financial year 2019-20, standalone total revenue at Arvee Laboratories (India) reached Rs.45.76 crore. PAT for FY20 was Rs.2.22 crore and Standalone EPS was Rs.4.04.